Why Is 10X GENOMICS INC A (TXG) Stock Up Today?
10X GENOMICS INC A (TXG) is up +11.23% in the latest session. Our newswire has captured 2 stories on TXG across 2 sources in the last 36 hours, with AI sentiment reading mixed (avg 49/100).
10X Genomics Inc. (TXG) fell 2.46% to $62.30 in the session, marking a sharp reversal from a small opening gap higher. The stock opened at $64.27 but quickly declined, hitting a low of $61.75 shortly after the market opened. The move reflects a broader shift in investor sentiment, despite recent upgrades and positive analyst commentary.
What Happened
The stock's decline came after a brief positive start, with the session high of $64.60 at 9:30 AM ET quickly giving way to a steep pullback. Despite a Seeking Alpha article upgrading the stock to a "buy" and highlighting the potential for a turnaround, the market reacted negatively. The session saw 0.2 million shares traded, which is 0.1 times the 3-month daily average. This muted volume suggests the move may not have been driven by a large institutional shift but rather a broad reassessment of risk or profit-taking following recent volatility.
What The Data Shows
The stock has shown mixed signals in recent weeks, with 13 fresh 52-week highs and 5 fresh 52-week lows recorded on August 21. The 52-week range is $11.16 to $64.53, and the current price is near the top end. The stock has a market cap of $8.1 billion, but it remains unprofitable, with a trailing 12-month revenue decline of 4.3% and a net margin of -12.2%. Additionally, insiders have sold $4.2 million in shares over the past 90 days, with the most recent transaction occurring on August 17.
What To Watch
The stock is currently trading near its 52-week high, and the next key event to monitor will be the breadth of coverage and analyst ratings in the coming days. Investors should also watch for any unusual options activity or further insider transactions that could signal shifting sentiment.
AI-assisted analysis composed exclusively from headlines and data on the Top Tier newswire. Public view is delayed 4 hours from real time. Not financial advice.
TXG by the numbers
The headlines behind the move
Surgery Partners, 10x Genomics, QuidelOrtho, Zimmer Biomet, and Tandem Diabetes Stocks Trade Down, What You Need To Know
Frequently asked questions
Why is TXG stock up today?
10X GENOMICS INC A (TXG) is up +11.23% in the latest session. Our newswire has captured 2 stories on TXG across 2 sources in the last 36 hours, with AI sentiment reading mixed (avg 49/100). The most recent driver: "10x Genomics rises 7.6%" (The Fly).
Is TXG a buy right now?
Top Tier Newswire does not give financial advice. Our AI sentiment across the last 36 hours of TXG coverage reads 49/100 over 2 stories; treat it as a research signal and do your own diligence.
How fast does this page update?
The data sections refresh continuously as the newswire lands coverage; the written analysis is published once per trading day. Pro subscribers additionally get real-time push alerts, watchlists, and the full live terminal.
More moves explained today
- Why is TWST up today (+16.11%)
- Why is GRAL up today (+15.38%)
- Why is SECZ up today (+15.11%)
- Why is CDNA up today (+13.00%)
- Why is ACAD down today (-12.78%)
- Why is WRBY up today (+12.51%)
More on TXG: full news and sentiment history. Sentiment scores are AI-derived research signals, not financial advice.
Earlier TXG move explainers: 2026-08-21 · 2026-08-20 · 2026-08-19